PATIENT AI Act Discussion Draft, AMA Issue Brief for Clinical AI Liability Released
Accountability and reimbursement for artificial intelligence (AI)-based technologies were highlighted topics of discussion last week.
Effective May 1, clinical diagnostic laboratories will be required to follow new data reporting requirements for clinical diagnostic laboratory tests that are not advanced diagnostic laboratory tests.
All independent, physician office, and hospital outreach laboratories that meet the definition of “applicable laboratory” under the Clinical Laboratory Fee Schedule (CLFS) will be subject to a data reporting period from May 1 to July 31, 2026, for the updated data collection period of Jan. 1 to June 30, 2025. This data collection period was updated according to language in Section 6226 of the Continuing Appropriations Act (CAA) of 2026, which was passed on Feb. 3, 2026.
The following data must be reported:
Another provision of the CAA delayed the phase-in of payment reductions under the CLFS from private payer rate implementation. Starting Jan. 1, 2027 to 2029, payment may not be reduced by more than 15 percent per year compared with the amount established for a test during the preceding year.
Sources:
https://www.cms.gov/medicare/payment/fee-schedules/clinical-laboratory-fee-schedule-clfs
Accountability and reimbursement for artificial intelligence (AI)-based technologies were highlighted topics of discussion last week.
Lincoln, NE – November 2026 TELCOR is proud to announce the promotion of Stephanie Gonnerman to Senior Analyst, Revenue Cycle Management (RCM).
The Centers for Medicare and Medicaid Services (CMS) released a report on Oct. 20 detailing significant differences in the share of reported test...